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Calculating The Risk Of Stroke 
Researchers have devised a method that will allow physicians—on the basis of a routine medical office 
evaluation—to determine the probability of a patient having a stroke within a certain number of years. 
Based on data obtained on more than 500 members of the Framingham Heart Study cohort who suffered 
strokes over a 34-year period, the new Framingham Stroke Risk Profile assigns a numerical value to 
information on age, sex, cigarette smoking, cardiac abnormalities and other measures of health, based on its 
relative importance as a risk factor for stroke. 
"The sum total of these numerical values helps predict a person's chance of having a stroke within a given 
period of time," says Philip Wolf, M.D., a professor of neurology and epidemiology at Boston University School 
of Medicine (BUSM) and the principal investigator of the Framingham Heart Study. 
Wolf uses as an example the average 10-year probability of stroke for a 70-year-old woman, which is 11 
percent. However, if that woman smokes and has high blood pressure and diabetes, her risk soars to more 
than 37 percent. 
According to Wolf, the profile may help patients understand their personal risk and may improve compliance 
with preventive measures. "If you tell someone he has a three or four times increased risk of stroke or a 
25-percent chance of having a stroke within five years, he'll be much more likely to stop smoking cigarettes and 
take his high-blood-pressure medication than if you simply tell him he's at high risk for stroke." 
The Framingham Heart Study-^he largest and longest-running epidemiological study in the world—is 
federally funded through a contract to BUSM. 
Antl-AIDS Drug Shows Promise 
The drug ddl (dideoxyinosine) shows promise as an alternative to AZT in the treatment of AIDS or AIDS Related 
Complex, especially for people who do not tolerate or respond to AZT, according to a study in the New England 
Journal of Medicine. 
Ddl is a member of the same chemical group as AZT—the only FDA-approved treatment for AIDS—and 
works in the same way, by inhibiting an enzyme necessary to replicate the AIDS virus. AZT can have serious 
side effects, the most significant being the suppression of blood cells. 
Researchers at Boston City Hospital (BCH) and Boston University School of Medicine (BUSM) conducted the 
study in collaboration with University Hospital (UH) scientists. It involved giving daily doses of ddl to 34 patients 
with AIDS or AIDS Related Complex for a median of 12 weeks. While several patients developed serious side 
effects, such as inflammation of the pancreas and nerve damage in the legs, no patient had the suppression of 
white blood cells or anemia associated with AZT. In fact, there was a significant improvement In blood counts 
after treatment with ddl, even among patients intolerant to AZT. 
Although the study's purpose was to determine the maximum safe dosage, researchers did find clinical 
improvements in the majority of patients. There was a significant increase in T4 lymphocytes—the white blood 
cells infected by the AIDS virus—and a decrease in the HIV antigen that reflects the level of the virus in the 
blood. In addition, the majority of patients experienced Increased energy and appetite and gained weight. 
"The results are very promising," says Timothy Cooley, M.D., a co-investigator of the study. "If further 
research confirms these findings, ddl will be an important treatment option, especially for patients intolerant or 
unresponsive to AZT." , , 
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The University Hospital And Boston Athletic Club Join Forces For Total Wellness 
People who work out at a Boston health club will now be more likely to sustain their fitness and exercise efforts 
with the help of a new on-site sports medicine center—New England's first joint hospital/health club center. 
Called the Boston Center For Physical Therapy and Sports Medicine and sponsored by the Boston Athletic Club 
(BAC) and the University Hospital (UH), the center offers sports-injury prevention and on-the-spot evaluation and 
treatment as well as access to the services of a teaching hospital. 
"Fitness is not possible without an already well body," says Anthony Schepsis, M.D., a UH orthopedic 
surgeon who conceived of the joint program. "By working to prevent and heal injuries and by teaching individuals 
the correct way to exercise, you increase the chances they will stay with their f itness program." 
The center's staff—including Schepsis and orthopedic surgeon John Zlmmer, M.D., and UH physical 
therapists—^will act as injury-prevention consultants and resources to health-club staff. They will also provide, 
through various UH departments, educational programs on such topics as stress management, smoking 
cessation, nutrition, weight loss, heart health and women's health. In the event of an injury, the staff will evaluate 
and treat club members and refer them to UH for further care if needed. On-site to help them treat injuries is 
state-of-the-art technology, including electrical stimulation and isokinetic equipment. 
Although other health clubs have physical therapists on staff, this center differs because it has the advantage 
of an association with a hospital with all its specialties as backup, according to Judy Hershberg, M.S., P.T., 
director of physical therapy at UH and the director of the joint sports medicine center. 
The UH/BAC collaboration is an example of a new trend in the health-club industry. Says Jerry Martin, vice 
president and general manager of BAC: "Total physical and mental wellness is the goal of the '90s in this 
Industry." 
Violence During Pregnancy 
Pregnant women are more likely to be victims of violence if they are heavy alcohol or drug users and if their 
partners are multiple drug users—a finding that researchers at Boston University's Schools of Medicine and 
Public Health (BUSM/BUSPH) say has important implications for the delivery of health care to pregnant women. 
The study is published in the May issue of the American Journal of Public Health. 
BUSM/BUSPH researchers interviewed 1,243 pregnant women undergoing treatment at Boston City Hospital. 
Seven percent of the participants—^who were poor, inner-city, minority women—reported physical or sexual 
violence during pregnancy. However, Hortensla Amaro, Ph.D., an associate professor of public health and 
pediatrics at BUSM/BUSPH and the first author of the study, says the actual number may be much higher 
because women who are abused often deny the abuse. 
According to Amaro, one of the study's major findings was that pregnant women who drink heavily or use 
drugs and whose partners use multiple illicit drugs were twice as likely to experience violence during pregnancy 
than women who don't drink heavily and whose partners do not use drugs. 
Amaro says: "The study suggests that there is a need for a coordination of sen/ices between prenatal and 
obstetrical services and services for battered women. Those caring for pregnant women need to assess their 
risk of exposure to violence, and those who care for battered women need to provide better services to pregnant 
women." 
